Daily Washington Insider
  • Business
  • World
  • Science
  • Investing

Daily Washington Insider

  • Business
  • World
  • Science
  • Investing
Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation
next post
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

You may also like

John Hancock to join White Cliff Minerals Board

June 24, 2025

Altech Batteries Ltd$4M Placement to Advance Battery Projects

November 15, 2024

Canadian Investment Regulatory Organization Trade Resumption – CYG

June 20, 2025

Joe Cavatoni: Gold’s Key Driver Now, Catalyst for...

July 24, 2025

How to Invest in Gene Stocks and ETFs

August 29, 2025

Manganese Market Forecast: Top Trends for Manganese in...

January 23, 2026

Gold, Silver See Gains as Fed Continues to...

May 2, 2024

Oreterra Metals: Close on the Trail of a...

March 6, 2026

Steadright Grants Stock Options

December 25, 2025

SAGA Metals Appoints Vernon Shein, Former Exploration Manager...

May 15, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular

    • 1

      Hong Kong plans to install thousands of surveillance cameras. Critics say it’s...

    • 2

      UN experts urge Thailand not to deport dozens of Uyghurs to China where they face ‘real risk of torture’

    • 3

      Trump has assembled a team of China hawks. How will Beijing respond?

    • 4

      China executes man who plowed car into crowds in deadliest attack in a decade

    • 5

      How Calvin Klein and Tommy Hilfiger got caught in Trump’s trade war with China

    Categories

    • Business (1,462)
    • Investing (4,835)
    • Science (627)
    • World (3,687)
    Footer Logo
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: dailywashingtoninsider.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 dailywashingtoninsider.com | All Rights Reserved